Dr. Chang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3330 Lomita Blvd
Torrance, CA 90505Phone+1 310-517-4750
Summary
- Dr. Bryan Chang is a radiation oncologist in Torrance, CA and is affiliated with Torrance Memorial Medical Center. He received his medical degree from University of Connecticut School of Medicine and has been in practice 14 years. He specializes in gastrointestinal cancer, head & neck, and thoracic cancer and is experienced in intensity-modulated radiation therapy, radiosurgery, and sterotactic body radiotherapy.
Education & Training
- Yale-New Haven Medical CenterResidency, Radiation Oncology, 2004 - 2008
- University of MarylandInternship, Internal Medicine, 2003 - 2004
- Uconn School Of MedicineClass of 2003
Certifications & Licensure
- CA State Medical License 2008 - 2025
- CT State Medical License 2008 - 2014
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer Start of enrollment: 2010 Jan 26
- Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
- Pilot Trial of KD018 With Neo-Adjuvant Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Rectal Cancer Start of enrollment: 2014 Jul 01
Publications & Presentations
PubMed
- 7 citationsChemoradiation after FOLFIRINOX for borderline resectable or locally advanced pancreatic cancer.Brandon R. Mancini, Stacey Stein, Shane Lloyd, Charles E. Rutter, Edward James
Journal of Gastrointestinal Oncology. 2018-04-20 - 1 citationsA Long-Term Survivor of Metastatic Pancreatic Adenocarcinoma: Free of Recurrence 12 Years After Treatment of Oligometastatic Disease.John M. Stahl, Zenta Walther, Bryan W. Chang, Howard S. Hochster, Kimberly L. Johung
Cureus. 2017-02-02 - 151 citationsFinal analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancerStacey Stein, Edward Samuel James, Yanhong Deng, Xiangyu Cong, Jeremy S. Kortmansky
British Journal of Cancer. 2016-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: